InvestorsHub Logo
Followers 228
Posts 14924
Boards Moderated 1
Alias Born 03/29/2014

Re: kabunushi post# 63925

Wednesday, 06/22/2016 8:42:20 PM

Wednesday, June 22, 2016 8:42:20 PM

Post# of 732481
I completely agree.

It is my very clear understanding as well that there will be a BMY/NWBO trial at UCLA in recurrent GBM because Dr. Prins talked about it as well. :)

And yes, they could do another trial pairing Opdivo with say Direct instead of L... possibly at MD Anderson. I am really so not fond of MD Anderson but I know they like Dr. Subbiah a lot. So maybe that one could be, wherever it is done, for non-small-cell lung cancer?

That's a different "combination treatment" (but still with BMY but at another location - hence, different parties)... which still fits with the wording.

Merck may fit in there too. Of BMY I am sure of. Of Merck, I'm not.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News